June 27 2023 - Diabetes tech: a catalyst rich sector with a dazzling future
Careers Information from across the Internet
×
Attorney
Engineering
Healthcare Workers
HVAC Technicians
Plumbing Services
Accountants
Teachers
HR Management
Scientists
Data Security Experts
Consultants
Report Site
Privacy Policy
Terms And Conditions
View All Posts
Subscribe To Our Newsletter
Menu
Careers Information from across the Internet
Attorney
Doctors
Logistics
Financial Advisors
Software Developers
June 27 2023 - Diabetes tech: a catalyst rich sector with a dazzling future
Diabetes tech: a catalyst rich sector with a dazzling future Aldeyra's roller coaster month ends..
January 26 2024 - After Padcev combo’s major triumph, Merck’s Keytruda delivers partial win in..
After Padcev combo’s major triumph, Merck’s Keytruda delivers partial win in bladder cancer ..
Happy Holidays from Cafepharma!
We hope you're having an enjoyable holiday season. We will be updating the front page news on a..
November 20 2023 - Bayer's blood thinner fails Eliquis test, sinking phase 3 trial and denting $5B..
Bayer's blood thinner fails Eliquis test, sinking phase 3 trial and denting $5B sales forecast AZ..
November 28 2023 - Merck strides onto Pfizer’s turf, posting pivotal vaccine data and heading to..
Merck strides onto Pfizer’s turf, posting pivotal vaccine data and heading to regulators Novo to..
August 22 2023 - Teva to pay $225M in DOJ generic drug price-fixing settlement
Teva to pay $225M in DOJ generic drug price-fixing settlement Fulcrum's sickle cell disease..
August 29 2023 - Biden administration lists 10 drugs for Medicare price negotiation
Biden administration lists 10 drugs for Medicare price negotiation 5 of the best places to work in ..
July 20 2023 - Pfizer plant in North Carolina severely damaged by tornado
Pfizer plant in North Carolina severely damaged by tornado Janssen’s newly-merged infectious..
July 24 2023 - Gilead drug acquired in $5B buyout fails key blood cancer trial
Gilead drug acquired in $5B buyout fails key blood cancer trial Roche, Alnylam ink potential $2.8B ..
July 31 2023 - US continues to be a top destination for pharma jobs in recent months
US continues to be a top destination for pharma jobs in recent months Apellis eye injection..
June 19 2023 - BMS follows Merck's lead, sues government over drug pricing negotiation
BMS follows Merck's lead, sues government over drug pricing negotiation Late-stage pipeline for..
June 29 2023 - Eli Lilly to buy Sigilon Therapeutics to expand diabetes treatments
Eli Lilly to buy Sigilon Therapeutics to expand diabetes treatments Former J&J sales rep indicted..
Quitting Smoking in Orange County, CA: Resources and Services to Help You
Quitting smoking can be a difficult process, but there are many resources and services available in ..
Free Prescription Drug Programs in Orange County, CA
Are you looking for free prescription drug programs in Orange County CA? The Medication Assistance..
April 25 2023 - Busy with 3 program launches this year, Biogen trims pipeline
Busy with 3 program launches this year, Biogen trims pipeline Medtronic wins FDA approval for..
April 26 2023 - US Senate kicks off fresh round of drug pricing control legislation
US Senate kicks off fresh round of drug pricing control legislation FDA approves Biogen and Ionis’ ..
Pet Pharmacies in Orange County, CA: Get the Best Medication for Your Furry Friend
Welby Affordable Animal Hospital and Orange Express Pharmacy offer a wide range of compounded..
April 27 2023 - FDA approves first oral microbiome therapy Vowst
FDA approves first oral microbiome therapy Vowst EU publishes proposed drug laws overhaul, setting ..
March 20 2023 - Will Sanofi and Regeneron's Dupixent be a game-changer for COPD?
Will Sanofi and Regeneron's Dupixent be a game-changer for COPD? Amazon closes blockbuster deal..
Where to Find the Best Independent Pharmacies in Orange County, CA
Are you looking for an independent pharmacy in Orange County? MedLife Pharmacy, Total Care Rx..
March 23 2023 - Moderna's gene therapy expansion picks up pace with $76M upfront Generation Bio..
Moderna's gene therapy expansion picks up pace with $76M upfront Generation Bio collab Disgraced..
March 28 2023 - Vertex ponies up $100M for CRISPR's gene editing tech to develop new diabetes..
Vertex ponies up $100M for CRISPR's gene editing tech to develop new diabetes modality Bicycle,..
March 30 2023 - Top biotech licensing deals of Q1 2023
Top biotech licensing deals of Q1 2023 Pfizer, BMS' Eliquis tops list of drugs destined for..
March 7 2023 - AbbVie CEO Gonzalez scored $26M in 2022 pay as cash cow Humira neared patent cliff
AbbVie CEO Gonzalez scored $26M in 2022 pay as cash cow Humira neared patent cliff What ancient..
February 17 2023 - Pfizer, Valneva remove half of participants from study of Lyme disease shot
Pfizer, Valneva remove half of participants from study of Lyme disease shot Merck seeks more..
January 23 2023 - FDA considers major shift in COVID vaccine strategy
FDA considers major shift in COVID vaccine strategy Biogen/ Ionis ALS therapy set for March FDA..
January 30 2023 - Amgen, navigating 'industry headwinds,' puts 300 commercial jobs on chopping block
Amgen, navigating 'industry headwinds,' puts 300 commercial jobs on chopping block The end of the..
January 31 2023 - Pfizer’s full-year revenues grow 23%, top $100B
Pfizer’s full-year revenues grow 23%, top $100B UniQure nabs another gene therapy for ALS Inovio..
January 10 2023 - BioNTech buys UK AI start-up InstaDeep in £562mn deal
BioNTech buys UK AI start-up InstaDeep in £562mn deal Supreme Court rebuffs Pfizer plan to help..
January 12 2023 - Did storms steal JPM's thunder?
Did storms steal JPM's thunder? Oramed's oral insulin flunks phase 3 diabetes test, sending stock..
January 13 2023 - Novo Nordisk's GLP-1 for Type II diabetes approved for first-line treatment
Novo Nordisk's GLP-1 for Type II diabetes approved for first-line treatment Roche searches for..
January 17 2023 - Pfizer pledges to sell all of its products at cost to poor countries
Pfizer pledges to sell all of its products at cost to poor countries Boehringer, Takeda make it..
previous post
